Results 251 to 260 of about 55,959 (291)

Prevalence and Risk Factors of Clinically Significant Potential Drug–Drug Interactions in Turkish Pediatric Intensive Care Units: Results From a Nationwide Point Prevalence Study

Journal of Clinical Pharmacy and Therapeutics, Volume 2026, Issue 1, 2026.
Objective Polypharmacy is a major concern in pediatric intensive care units (PICUs), where critically ill children receive multiple medications, increasing the risk of clinically significant potential drug–drug interactions (pDDIs). However, data on pDDI prevalence in PICUs remain limited.
Emel Uyar, Yunus Emre Ayhan, Feyza İnceköy Girgin, Cüneyd Enver, Betul Okuyan, Mesut Sancar, Nilüfer Yalındağ Öztürk, Turkish DDI Study Group, Amsalu Degu   +8 more
wiley   +1 more source

Inhibition of Rho‐kinase restores impaired relaxation of airway smooth muscle in rat pups exposed to neonatal hyperoxia

Physiological Reports, Volume 14, Issue 2, January 2026.
Abstract Neonatal hyperoxia is a key contributor to bronchopulmonary dysplasia (BPD) which is characterized by airway hyperreactivity due to increased contraction and impaired relaxation of airway smooth muscle (ASM). This study investigated whether inhibition of the Rho/Rho‐kinase signaling pathway restored tracheal smooth muscle (TSM) relaxation and ...
Ramadan B. Sopi, Qëndrim Thaçi, Thomas M. Raffay, Qëndresa Beqiraj‐Zeqiraj   +3 more
wiley   +1 more source

Personalizing therapies over the course of hormone receptor‐positive/HER2‐negative metastatic breast cancer

CA: A Cancer Journal for Clinicians, Volume 76, Issue 1, January/February 2026.
ABSTRACT The hormone receptor (HR)‐positive/human epidermal growth factor receptor 2 (HER2)‐negative breast cancer subtype accounts for most early and metastatic breast cancer (MBC) cases. HR‐positive/HER2‐negative MBC is characterized by a relatively prolonged, although variable, disease course and substantial intertumoral and intratumoral ...
Akshara Singareeka Raghavendra, Senthil Damodaran, Carlos H. Barcenas, Suzanne A. Fuqua, Rachel M. Layman, Debu Tripathy   +5 more
wiley   +1 more source

Comments on “QT interval prolongation in Takotsubo syndrome: a frightening feature with no major prognostic impact”

John E. Madias
openalex   +2 more sources

QT Interval Prolongation in Patients Treated for COVID-19

, 2020
Habibzadeh P, Sarami A, Yadollahie M, Hashemiasl K, Salahi A, Habibzadeh F.   +5 more
europepmc   +1 more source

Kawasaki Disease Shock Syndrome With Progressive AV Block and Atrioventricular Dissociation: Case Report

Journal of Paediatrics and Child Health, Volume 62, Issue 1, Page 118-122, January 2026.
Chengjun Dai, Jiao Chen, Yutong Chen, Yingchao Ying, Yanlan Fang, Zihao Yang, Chunlin Wang   +6 more
wiley   +1 more source

Personalized approach to prediction and prevention of haloperidol-induced QT interval prolongation: brief review

Р. Ф. Насырова, A. V. Kidyaeva, V. V. Grechkina, N. А. Shnayder   +3 more
openalex   +2 more sources